Technology1h ago
Precision Neuroscience Raises $250M as Surface BCI Bets Against Neuralink's Invasive Model
Bill Ackman's $42.5M bet on less invasive brain implants signals capital's turn away from single-neuron precision toward infection risk reduction and faster FDA approval paths.